ArticleCancer biotherapy & radiopharmaceuticals2008

Protein- and DNA-based active immunotherapy targeting interleukin-13 receptor alpha2.

Akiva Mintz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.